Results 281 to 290 of about 292,383 (379)
High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease. [PDF]
D'Onofrio B+11 more
europepmc +1 more source
Objective Our objective was to evaluate the efficacy and safety of subcutaneous (SC) abatacept and standard of care (SOC) for the treatment of idiopathic inflammatory myopathy (IIM) over 52 weeks. Methods In this randomized, double‐blind, placebo‐controlled phase III trial, patients with treatment‐refractory IIM received SC abatacept (at 125 mg weekly)
Rohit Aggarwal+5 more
wiley +1 more source
Genetic Association of Juvenile Idiopathic Arthritis With Adult Rheumatic Disease.
Fan J+14 more
europepmc +1 more source
Emerging Role and Mechanism of Mesenchymal Stem Cells-Derived Extracellular Vesicles in Rheumatic Disease. [PDF]
Wang Z+8 more
europepmc +1 more source
Objective Cutaneous lupus erythematosus (CLE) is an inflammatory skin manifestation of systemic lupus erythematosus. Type I interferons (IFNs) promote inflammatory responses and are elevated in CLE lesions. We recently reported that CLE lesions are frequently colonized with Staphylococcus aureus.
Lisa Abernathy‐Close+9 more
wiley +1 more source
Association between infertility and incident onset of systemic autoimmune rheumatic disease after childbirth: a population-based cohort study. [PDF]
Scime NV+5 more
europepmc +1 more source
Objective Endogenous retroelements (EREs) stimulate type 1 interferon (IFN‐I) production but have not been explored as potential interferonogenic triggers in rheumatoid arthritis (RA). We investigated ERE expression in early RA (eRA), a period in which IFN‐I levels are increased.
Faye A. H. Cooles+12 more
wiley +1 more source
Fatigue patterns surrounding biologic disease-modifying antirheumatic drug injection in patients with an inflammatory rheumatic disease: an ecological momentary assessment study. [PDF]
van Lint JA+5 more
europepmc +1 more source